| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |